Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study

Fig. 4

Visual gains and losses in the cohort stratified by treatment drug. (A) Number of patients gaining 15 or more ETDRS letters from baseline per treatment year. (B) Percentage of patients gaining 15 or more ETDRS letters from baseline per treatment year. (C) Number of patients losing 15 or more ETDRS letters from baseline per treatment year. (B) Percentage of patients gaining 15 or more ETDRS letters from baseline per treatment year

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us